NDC 60687-824 – Rufinamide
Rufinamide 40 mg/mL · Suspension · Oral
Product NDC60687-824
Product details
- Brand name
- Rufinamide
- Generic name
- Rufinamide
- Labeler
- American Health Packaging
- Dosage form
- Suspension
- Route
- Oral
- Marketing category
- ANDA · ANDA207363
- Marketed since
- January 6, 2026
- Marketing end
- May 31, 2027
Active ingredients
- Rufinamide 40 mg/mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 60687-824-08 | 3 TRAY in 1 CASE (60687-824-08) / 10 CUP, UNIT-DOSE in 1 TRAY (60687-824-48) / 10 mL in 1 CUP, UNIT-DOSE (60687-824-42) | Jan 6, 2026 |
Other Rufinamide products
- 67877-673 Rufinamide 40 mg/mL · Suspension · Ascend Laboratories, LLC
- 59651-563 Rufinamide 40 mg/mL · Suspension · Aurobindo Pharma Limited
- 69452-223 Rufinamide 40 mg/mL · Suspension · Bionpharma Inc.
- 31722-688 Rufinamide 40 mg/mL · Suspension · Camber Pharmaceuticals, Inc.
- 0054-0528 Rufinamide 40 mg/mL · Suspension · Hikma Pharmaceuticals USA Inc.
- 68180-797 Rufinamide 40 mg/mL · Suspension · Lupin Pharmaceuticals, Inc.
- 72603-261 Rufinamide 40 mg/mL · Suspension · NorthStar RxLLC
- 72205-038 Rufinamide 40 mg/mL · Suspension · Novadoz Pharmaceuticals LLC
- 59651-617 Rufinamide 400 mg/1 · Tablet, Film Coated · Aurobindo Pharma Limited
- 59651-616 Rufinamide 200 mg/1 · Tablet, Film Coated · Aurobindo Pharma Limited
- 31722-599 Rufinamide 400 mg/1 · Tablet, Film Coated · Camber Pharmaceuticals, Inc.
- 31722-598 Rufinamide 200 mg/1 · Tablet, Film Coated · Camber Pharmaceuticals, Inc.